These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26306397)

  • 1. Jugular venipuncture and other innovative approaches to phlebotomy among people who inject drugs.
    Ferguson C; Higgs P; Olsen A
    Nurs Health Sci; 2015 Dec; 17(4):539-41. PubMed ID: 26306397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences of UK patients with hepatitis C virus infection accessing phlebotomy: A qualitative analysis.
    Clements A; Grose J; Skirton H
    Nurs Health Sci; 2015 Jun; 17(2):214-22. PubMed ID: 25496414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "We don't need services. We have no problems": exploring the experiences of young people who inject drugs in accessing harm reduction services.
    Krug A; Hildebrand M; Sun N
    J Int AIDS Soc; 2015; 18(2 Suppl 1):19442. PubMed ID: 25724510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injection into the jugular vein among people who inject drugs in the United Kingdom: Prevalence, associated factors and harms.
    Hope VD; Iversen J; Cullen KJ; Parry JV; Maher L; Nucbe F
    Int J Drug Policy; 2017 Aug; 46():28-33. PubMed ID: 28586700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Blood letting"-Self-phlebotomy in injecting anabolic-androgenic steroids within performance and image enhancing drug (PIED) culture.
    Brennan R; Wells J; Van Hout MC
    Int J Drug Policy; 2018 May; 55():47-50. PubMed ID: 29518637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Views and experiences of hepatitis C testing and diagnosis among people who inject drugs: systematic review of qualitative research.
    Jones L; Atkinson A; Bates G; McCoy E; Porcellato L; Beynon C; McVeigh J; Bellis MA
    Int J Drug Policy; 2014 Mar; 25(2):204-11. PubMed ID: 24332457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of pluralistic ignorance on the provision of health care for people who inject drugs.
    Brener L; von Hippel C; Horwitz R; Hamwood J
    J Health Psychol; 2015 Sep; 20(9):1240-9. PubMed ID: 24271692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lived experience of hepatitis C and its treatment among injecting drug users: qualitative synthesis.
    Treloar C; Rhodes T
    Qual Health Res; 2009 Sep; 19(9):1321-34. PubMed ID: 19690211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoting treatment for hepatitis C in people who inject drugs: A review of the barriers and opportunities.
    J Am Assoc Nurse Pract; 2020 Aug; 32(8):569-570. PubMed ID: 32769590
    [No Abstract]   [Full Text] [Related]  

  • 10. Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs.
    Harris M; Rhodes T
    Addiction; 2012 Jun; 107(6):1090-6. PubMed ID: 22151433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study.
    Midgard H; Hajarizadeh B; Cunningham EB; Conway B; Backmund M; Bruggmann P; Bruneau J; Bourgeois S; Dunlop A; Foster GR; Hellard M; Robaeys G; Thurnheer MC; Weltman M; Amin J; Marks PS; Quiene S; Dore GJ; Dalgard O; Grebely J;
    Int J Drug Policy; 2017 Sep; 47():230-238. PubMed ID: 28633998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Beyond the willing & the waiting' - The role of peer-based approaches in hepatitis C diagnosis & treatment.
    Henderson C; Madden A; Kelsall J
    Int J Drug Policy; 2017 Dec; 50():111-115. PubMed ID: 28927831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection.
    Artenie AA; Zang G; Daniel M; Fortier E; Jutras-Aswad D; Puzhko S; Bruneau J
    Int J Drug Policy; 2017 Sep; 47():239-243. PubMed ID: 28587944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intimate relationship as a site of social protection: Partnerships between people who inject drugs.
    Rhodes T; Rance J; Fraser S; Treloar C
    Soc Sci Med; 2017 May; 180():125-134. PubMed ID: 28343111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination by health care workers versus discrimination by others: countervailing forces on HCV treatment intentions.
    Brener L; Horwitz R; von Hippel C; Bryant J; Treloar C
    Psychol Health Med; 2015; 20(2):148-53. PubMed ID: 24889417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs.
    Treloar C; Hull P; Bryant J; Hopwood M; Grebely J; Lavis Y
    Drug Alcohol Depend; 2011 Jul; 116(1-3):52-6. PubMed ID: 21194852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in planning ability and hepatitis C virus among people who inject drugs.
    Scheidell JD; Khan MR; Clifford LM; Dunne EM; Keen LD; Latimer WW
    Addict Behav; 2015 Aug; 47():33-7. PubMed ID: 25863005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.
    Aspinall EJ; Weir A; Sacks-Davis R; Spelman T; Grebely J; Higgs P; Hutchinson SJ; Hellard ME
    Int J Drug Policy; 2014 Jan; 25(1):179-82. PubMed ID: 24315504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception.
    Safo SA; Batchelder A; Peyser D; Litwin AH
    Harm Reduct J; 2015 Jun; 12():20. PubMed ID: 26092261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.